Fera Pharmaceuticals announced the launch today of four ophthalmic ointments.
“Achieving this important milestone for our company, while bringing these needed products to the market, is extremely rewarding”
Neo-Polycin™; Neo-Polycin™ HC; Polycin™; Neomycin and Polymyxin B Sulfates with Dexamethasone Ophthalmic Ointments are the latest additions to the Fera product offering making it the largest Rx ophthalmic ointment portfolio available in the US.
"Achieving this important milestone for our company, while bringing these needed products to the market, is extremely rewarding," says Frank DellaFera, Fera President.
Croatian sea fennel may contain a treasure trove of preservative and anti-aging metabolites